Out of Stock-5%Rx only
ATCO LABORATORIES LIMITED
A-glip Tablets 100mg (1 Box = 14 Tablets)
1 Box(s) × 14 Units
Rated 0.0 out of 5 (0)
Rs. 428.26Rs. 450.81
Out of Stock
-5%
Out of Stock-5%
Out of StockSAFFRON PHARMACEUTICAL COMP
Alosita-Met Tablets 50/500mg (1 Strip = 7 Tablets)
Rated 0.0 out of 5 (0)SKU 1000000020454
Buy ALOSITA-MET 50/500MG from SAFFRON PHARMACEUTICAL COMP and get it delivered at your door step only from Dvago
Rs. 239.40Rs. 252-5%
You save Rs. 12.60
1 Strip(s) × 7 Tablets
Out of StockSet your city for an exact delivery date
Out of stock items cannot be added to the cart. Call us on 021-111-HOPE and we will tell you when the next delivery lands.
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 239.40
By increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.
It is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.
- Diabetes
For patients with type 2 diabetes mellitus, whose hyperglycemic is inadequately controlled with diet and exercise alone, the recommended starting dose of (Sitagliptin + Metformin HCl) is 50mg of Sitagliptin + 500mg of Metformin HCl twice daily. Patients may be titrated upto 50mg Sitagliptin + 1000mg of Metformin HCl twice daily. The dosage of (Sitagliptin + Metformin HCl) should be individualized on the basis of patient’s current regimen, effectiveness and tolerability while not exceeding the maximum recommended daily dose of 100mg Sitagliptin.
Sitagliptin, Metformin
- Since impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.
- Patient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.
- After initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by SAFFRON PHARMACEUTICAL COMP. Country of origin: Pakistan.
0.0
Rated 0.0 out of 50 verified ratings
- 5★0%
- 4★0%
- 3★20%
- 2★40%
- 1★0%
- Sana MalikVerified Purchase4 Aug 2026Rated 0.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength. Prescription was verified by phone before dispatch, which built confidence.
- Imran Q.Verified Purchase24 Jul 2026Rated 2.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Zainab H.Verified Purchase9 Jul 2026Rated 3.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Hina RazaVerified Purchase20 Jun 2026Rated 2.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Kamran AliVerified Purchase13 Jun 2026Rated 0.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
By increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.
It is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.
- Diabetes
For patients with type 2 diabetes mellitus, whose hyperglycemic is inadequately controlled with diet and exercise alone, the recommended starting dose of (Sitagliptin + Metformin HCl) is 50mg of Sitagliptin + 500mg of Metformin HCl twice daily. Patients may be titrated upto 50mg Sitagliptin + 1000mg of Metformin HCl twice daily. The dosage of (Sitagliptin + Metformin HCl) should be individualized on the basis of patient’s current regimen, effectiveness and tolerability while not exceeding the maximum recommended daily dose of 100mg Sitagliptin.
Sitagliptin, Metformin
- Since impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.
- Patient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.
- After initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by SAFFRON PHARMACEUTICAL COMP. Country of origin: Pakistan.
0.0
Rated 0.0 out of 50 verified ratings
- 5★0%
- 4★0%
- 3★20%
- 2★40%
- 1★0%
- Sana MalikVerified Purchase4 Aug 2026Rated 0.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength. Prescription was verified by phone before dispatch, which built confidence.
- Imran Q.Verified Purchase24 Jul 2026Rated 2.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Zainab H.Verified Purchase9 Jul 2026Rated 3.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Hina RazaVerified Purchase20 Jun 2026Rated 2.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Kamran AliVerified Purchase13 Jun 2026Rated 0.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
ESSA LAB25-Hydroxy Vitamin D TestRs. 3,460Rated 0.0 out of 5
SANTE (PRIVATE) LIMITED2Blink Eye Drops 15mlRs. 500.56Rated 0.0 out of 5
Bundle total
Rs. 3,960.56Rs. 3,986.91
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
More in this range
Out of Stock
